Stryker Corporation's Fiscal Year is From January To December.
The item "Price-To-Cashflow-Ratio" stands at 29.05 as of 09/30/2025, the lowest value since 09/30/2022.
As of the end of Stryker Corporation's third quarter, the item "Price To Cashflow Ratio" stands at 29.05. This represents a decrease of -6.57 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -17.43 percent compared to the value the year prior.
The 1 year change in percent is -17.43.
The 3 year change in percent is -1.25.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Price To Cashflow Ratio | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Price To Cashflow Ratio | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Price To Cashflow Ratio | 172,241,486,586.05 |
![]() | Danaher Corporation - Price To Cashflow Ratio | 162,006,663,168.00 |
![]() | Boston Scientific Corp - Price To Cashflow Ratio | 144,567,730,176.00 |